<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: The aim of this study was to assess LA function by two-dimensional speckle-tracking echocardiography and its relation with <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo> in <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> (HCM) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We enrolled 30 consecutive HCM-patients in our study (20 males; age: 49.7 +/- 10.4 years, NYHA-class: 1.9 +/- 0.7) </plain></SENT>
<SENT sid="2" pm="."><plain>Echocardiography was performed with assessment of global longitudinal LV strain (epsilon) and LA epsilon and strain-rate parameters (systolic, early diastolic, and late diastolic during atrial contraction) </plain></SENT>
<SENT sid="3" pm="."><plain>Each patient received delayed-enhancement magnetic resonance imaging (DE-MRI) to check for <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>We divided the patients into two groups </plain></SENT>
<SENT sid="5" pm="."><plain>Patients of group 1 had no <z:mp ids='MP_0003045'>fibrosis</z:mp>, group 2 demonstrated moderate or severe <z:mp ids='MP_0003045'>fibrosis</z:mp> in &gt; or = 2 segments using a 17 segment-model of the LV </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Moderate and severe <z:mp ids='MP_0003045'>fibrosis</z:mp> was observed in 20 patients (group 2: 66.7%) </plain></SENT>
<SENT sid="7" pm="."><plain>Global longitudinal LV epsilon (-13.0 +/- 2.4 vs -20.6 +/- 3.2%, P &lt; 0.001) and peak LA epsilon (-0.2 +/- 3.9 vs 17.9 +/- 6.7%, P &lt; 0.001) were reduced in group 2 in comparison with patients without <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> patients peak LA epsilon correlated with global longitudinal LV epsilon (r = -0.78, P &lt; 0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>Patients with considerable <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo> (group 2) had a higher indexed left atrial volume (35.7 +/- 12.8 ml/m2 vs 24.1 +/- 8.6 ml/m2, P = 0.016) </plain></SENT>
<SENT sid="10" pm="."><plain>New York Heart Association class (NYHA) was higher in patients with severe <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo> (2.2 +/- 0.7 vs 1.3 +/- 0.5) and correlated with peak LA (r = -0.5, P = 0.008) and global LV epsilon (r = 0.5, P = 0.005) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Occurrence of <z:hpo ids='HP_0001685'>myocardial fibrosis</z:hpo> in <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> is associated with left atrial and ventricular dysfunction as well as with the severity of <z:hpo ids='HP_0001635'>heart failure</z:hpo> symptoms </plain></SENT>
</text></document>